Litigation Details for In re McKesson Corporation Derivative Litigation (N.D. Cal. 2017)
✉ Email this page to a colleague
In re McKesson Corporation Derivative Litigation (N.D. Cal. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-04-03 |
Court | District Court, N.D. California | Date Terminated | 2020-04-22 |
Cause | 28:1332 Diversity-Breach of Contract | Assigned To | Claudia Ann Wilken |
Jury Demand | Plaintiff | Referred To | |
Parties | JOHN H. HAMMERGREN | ||
Patents | 8,647,605 | ||
Attorneys | Kevin Michael Askew | ||
Firms | Bernstein Litowitz Berger & Grossman LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in In re McKesson Corporation Derivative Litigation
Details for In re McKesson Corporation Derivative Litigation (N.D. Cal. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-12-28 | 66 | Sale + Options Exercise $115.30 75,000 $8,647,605.00 594,343 May 28, 2013 John Hammergren…Moreover, the 220 Production shows that they devoted patently 12 inadequate time or consciously disregarded | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |